165 related articles for article (PubMed ID: 33725905)
1. A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus.
Nakamura Y; Haraguchi A; Shigeno R; Ito A; Horie I; Kawakami A; Abiru N
Medicine (Baltimore); 2021 Mar; 100(10):e25100. PubMed ID: 33725905
[TBL] [Abstract][Full Text] [Related]
2. 5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function.
Ota U; Hara T; Nakagawa H; Tsuru E; Tsuda M; Kamiya A; Kuroda Y; Kitajima Y; Koda A; Ishizuka M; Fukuhara H; Inoue K; Shuin T; Nakajima M; Tanaka T
BMC Pharmacol Toxicol; 2017 Jan; 18(1):7. PubMed ID: 28132645
[TBL] [Abstract][Full Text] [Related]
3. Pilot Trial on the Effect of 5-Aminolevulinic Acid on Glucose Tolerance in Patients with Maternally Inherited Diabetes and Deafness.
Nakamura Y; Haraguchi A; Horie I; Kawakami A; Abiru N
Diabetes Ther; 2023 Feb; 14(2):447-459. PubMed ID: 36418716
[TBL] [Abstract][Full Text] [Related]
4. Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant).
Sumiyoshi R; Koga T; Shimizu T; Sato S; Tashiro S; Hosogaya N; Yamamoto H; Kawakami A
Medicine (Baltimore); 2020 Dec; 99(50):e22708. PubMed ID: 33327226
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.
Shimura M; Nozawa N; Ogawa-Tominaga M; Fushimi T; Tajika M; Ichimoto K; Matsunaga A; Tsuruoka T; Kishita Y; Ishii T; Takahashi K; Tanaka T; Nakajima M; Okazaki Y; Ohtake A; Murayama K
Sci Rep; 2019 Jul; 9(1):10549. PubMed ID: 31332208
[TBL] [Abstract][Full Text] [Related]
6. The Safety and Tolerability of 5-Aminolevulinic Acid Phosphate with Sodium Ferrous Citrate in Patients with Type 2 Diabetes Mellitus in Bahrain.
Al-Saber F; Aldosari W; Alselaiti M; Khalfan H; Kaladari A; Khan G; Harb G; Rehani R; Kudo S; Koda A; Tanaka T; Nakajima M; Darwish A
J Diabetes Res; 2016; 2016():8294805. PubMed ID: 27738640
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model.
Hu X; Que W; Hirano H; Wang Z; Nozawa N; Ishii T; Ishizuka M; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Guo WZ; Li XK
Cancer Sci; 2021 Jul; 112(7):2652-2663. PubMed ID: 33934440
[TBL] [Abstract][Full Text] [Related]
8. Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats.
Hara T; Koda A; Nozawa N; Ota U; Kondo H; Nakagawa H; Kamiya A; Miyashita K; Itoh H; Nakajima M; Tanaka T
FEBS Open Bio; 2016 Jun; 6(6):515-28. PubMed ID: 27239432
[TBL] [Abstract][Full Text] [Related]
9. Sodium ferrous citrate and 5-aminolevulinic acid improve type 2 diabetes by maintaining muscle and mitochondrial health.
Kitamura N; Zhang S; Morel JD; Nagano U; Taworntawat T; Hosoda S; Nakamura A; Ogawa Y; Benegiamo G; Auwerx J; Tsubota K; Yokoyama Y; Watanabe M
Obesity (Silver Spring); 2023 Apr; 31(4):1038-1049. PubMed ID: 36823345
[TBL] [Abstract][Full Text] [Related]
10. 5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice.
Saitoh S; Okano S; Nohara H; Nakano H; Shirasawa N; Naito A; Yamamoto M; Kelly VP; Takahashi K; Tanaka T; Nakajima M; Nakajima O
PLoS One; 2018; 13(1):e0189593. PubMed ID: 29364890
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
Wang Z; Ma K; Liu C; Hu X; Que W; Ito H; Takahashi K; Nakajima M; Tanaka T; Ren K; Guo WZ; Yi SQ; Li XK
Drug Discov Ther; 2021 Jan; 14(6):304-312. PubMed ID: 33390570
[TBL] [Abstract][Full Text] [Related]
12. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
Liu C; Wang Z; Hu X; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Li XK
Int Immunopharmacol; 2021 Jul; 96():107626. PubMed ID: 33862551
[TBL] [Abstract][Full Text] [Related]
13. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation.
Suzuki S; Hinokio Y; Ohtomo M; Hirai M; Hirai A; Chiba M; Kasuga S; Satoh Y; Akai H; Toyota T
Diabetologia; 1998 May; 41(5):584-8. PubMed ID: 9628277
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis.
Negoro H; Chatziantonio C; Razzaque MS
Expert Rev Anti Infect Ther; 2022 May; 20(5):657-661. PubMed ID: 34927515
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic acid bypasses mitochondrial complex I deficiency and corrects physiological dysfunctions in Drosophila.
Nozawa N; Noguchi M; Shinno K; Saito T; Asada A; Ishii T; Takahashi K; Ishizuka M; Ando K
Hum Mol Genet; 2023 Aug; 32(16):2611-2622. PubMed ID: 37364055
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron.
Ito H; Nishio Y; Hara T; Sugihara H; Tanaka T; Li XK
Eur J Pharmacol; 2018 Aug; 833():25-33. PubMed ID: 29753693
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic acid combined with ferrous iron improves glucose tolerance in high-fat diet-fed mice via upregulation of glucose transporter 1.
Kuroda Y; Kamiya A; Ishii T; Ishizuka M; Yamashita Y; Ashida H
Exp Ther Med; 2021 Dec; 22(6):1454. PubMed ID: 34737794
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
Osei K; Gaillard T; Schuster D
Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5-aminolevulinic acid supplementation on home-based walking training achievement in middle-aged depressive women: randomized, double-blind, crossover pilot study.
Suzuki H; Masuki S; Morikawa A; Ogawa Y; Kamijo YI; Takahashi K; Nakajima M; Nose H
Sci Rep; 2018 May; 8(1):7151. PubMed ID: 29740015
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer.
Kawamura K; Matsushima H; Sakai H; Iwashima A; Nakamura S; Kojima T; Sasaki S; Shigenaga T; Natsume I; Sasaki T; Ohsaki Y; Iwanaga K; Nishi K; Mitsuishi Y; Taniguchi H; Sato K; Yamauchi M; Nakajima M; Takahashi K
Oncology; 2022; 100(11):620-632. PubMed ID: 36099876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
